All lobbying filings

THE UNITED STATES PHARMACOPEIAL CONVENTION

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $110,000.00 expenses · posted Jul 21, 2025

Official filing document

Bills named in this filing 2

S 1784
MAPS Act
HR 4191
MAPS Act

Lobbying activity 1

Health Issues

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.